Predictors of Supplemental Opioid Use After Third Molar Extraction

Area of Science:

• Oral and Maxillofacial Surgery
• Pain Management
• Pharmacology

Background:

• Non-steroidal anti-inflammatory drugs (NSAIDs) are first-line analgesics for third molar extraction.
• Some patients require supplemental opioids for adequate pain control.
• Identifying predictors of opioid use can optimize pain management strategies.

Purpose of the Study:

• To identify demographic and clinical factors predicting supplemental opioid use.
• To analyze predictors in patients receiving an evidence-based analgesic regimen.
• To evaluate factors associated with breakthrough pain management post-extraction.

Main Methods:

• 85 healthy adults undergoing mandibular third molar extraction.
• Randomized, double-blind comparison of ibuprofen vs. placebo for initial pain.
• Transition to open-label ibuprofen + acetaminophen, with oxycodone for breakthrough pain.
• Logistic regression analysis to identify predictors of supplemental opioid use.

Main Results:

• 20% of participants (17/85) used supplemental oxycodone.
• Female sex (OR: 6.77) and higher BMI (OR: 1.25) increased odds of opioid use.
• Higher pre-surgery neutrophil counts (OR: 0.435) decreased odds of opioid use.
• Surgical difficulty (Pederson score) did not significantly predict opioid use.

Conclusions:

• Female sex, elevated BMI, and pre-surgery neutrophil counts are key predictors of supplemental opioid needs.
• The findings aid in personalized pain management protocols for third molar surgery.
• Evidence-based analgesic regimens effectively manage pain for most patients, but individual factors influence opioid requirements.